Burden of Rubella virus infection among females attending tertiary care hospitals of Odisha, India: a need for adult women vaccination

Hum Vaccin Immunother. 2021 Oct 3;17(10):3757-3760. doi: 10.1080/21645515.2021.1935168. Epub 2021 Jun 23.

Abstract

Rubella is a contagious disease caused by rubella virus leading to adverse outcomes among pregnant women including abortions, low birth weight, stillbirths and congenital rubella syndrome (CRS) in the baby. If not pregnant, the clinical manifestations are mild and self-limiting. In this hospital based cross-sectional study, 1985 blood samples were collected from females attending outpatient services of various hospitals to serologically detect Rubella infection. Rubella antibodies namely Immunoglobulin M (IgM)/Immunoglobulin G (IgG) were detected through enzyme linked immunosorbent assay (ELISA) or by identifying virus through polymerase chain reaction (PCR). From the total enrolled participants, 1951 samples were tested with age ranging from 16 to 38 years. Among the positive samples, about 60% patients had IgG antibodies as compared to less than 1% IgM and 0.40% by PCR. Out of 1951 samples, 7/849 (0.82%) and 651/1070 (60.8%) had IgM & IgG rubella antibodies respectively. The odds of having abortion was [OR-13.14 (4.94-34.97)] among anti-rubella positive and primi-gravida [OR-43.6 (5.9-322)] women. Therefore, vaccination of women against rubella before planning of pregnancy or at adolescence seems to be the need of hour to avoid the ill consequences during pregnancy as well as for the new born baby.

Keywords: Epidemiology; India; pregnancy; rubella virus; sero-surveillance; vaccination.

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral
  • Cross-Sectional Studies
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Immunoglobulin M
  • Pregnancy
  • Pregnancy Complications, Infectious* / epidemiology
  • Pregnancy Complications, Infectious* / prevention & control
  • Rubella virus
  • Rubella* / epidemiology
  • Rubella* / prevention & control
  • Tertiary Care Centers
  • Vaccination
  • Young Adult

Substances

  • Antibodies, Viral
  • Immunoglobulin M